Objectives: Carbapenem resistance is a serious clinical and public health threat. Carbapenemase can confer carbapenem resistance, and most carbapenemase genes are plasmid encoded so resistance can easily spread. In this study, we aimed to develop a novel system based on the TaqMan platform for the rapid detection of 6 clinically prevalent carbapenemase genes: Klebsiella pneumoniae carbapenemase, New Delhi metallo-β-lactamase, oxacillinase, imipenem-hydrolyzing, Verona integron-encoded metallo-β-lactamase, and Guiana extended-spectrum β-lactamase. Methods: The triplex assay was verified by testing genomic DNA of 6 carbapenemase-producing Klebsiella pneumoniae. It was validated with a blinded panel of 310 Enterobacteriaceae isolates, including 225 carbapenemase-producers and 85 non-producers, by direct colony triplex real-time polymerase chain reaction (PCR). The real-time PCR was performed using the ABI 7500 fast instrument (Applied Biosystems, CA, USA) and specific primers for each carbapenemase target were designed to include modified peptide-nucleic acid oligonucleotides. Results: No amplification was detected among the negative samples. The result showed 100% concordance with the genotypes previously identified. The entire assay, including DNA extraction and real-time PCR, was completed within 2 hours. Conclusion: The newly developed triplex real-time PCR assay was useful for the rapid, accurate and simultaneous detection of 6 carbapenemase genes in Enterobacteriaceae, suggesting its potential to allow an early decision on the appropriate treatment, management, and prevention of the spread of resistant infections in hospitals.
Introduction
Enterobacteriaceae is the largest family of gram-negative bacteria that are significant causes of community-and healthcare-associated human infections. In particular, the considerable increase of multidrug-resistant Enterobacteriaceae with extended spectrum β-lactamase (ESBL) poses a serious clinical challenge as these infections are increasingly difficult to control in many hospitals [1] [2] [3] . Carbapenems, given their broad spectrum of antibacterial activity against hydrolysis by most β-lactamases, are agents currently regarded as the last-line of defense for the treatment of infections by ESBL producers [4] [5] [6] . The increased use of carbapenems has led to an emergence of carbapenem-resistant Enterobacteriaceae
In this study, two triplex real-time PCR assays for the simultaneous detection of 6 carbapenemase genes were developed, reducing the turn-around time of screening carbapenemase producers in hospital laboratories, and in large-scale surveillance. To improve the specificity of this assay, the modified peptide-nucleic acid (PNA) oligonucleotides technique was adopted. PNA is an artificially synthesized nucleic acid analogue in which the phosphate-ribose backbone of DNA is replaced with a peptide-like amide backbone, and therefore exhibits a stronger binding affinity and a higher specificity to the target DNA for molecular diagnosis [28, 29] .
The assays were optimized by using direct colony PCR, without complex sample preparation, and the results and performance were compared to the conventional PCR method.
This developed triplex real-time format assay is widely accessible to clinical diagnosis for rapid detection of the carbapenemase enzyme in Enterobacteriaceae.
Materials and Methods

Bacterial strains
Six reference strains of K. pneumoniae were used to verify the assay: CKPN20100021 with bla KPC , CKPN20160166 with bla NDM , CKPN20140654 with bla OXA-48 like , CKPN20130418 with bla IMP , CKPN20140712 with bla VIM , and CKPN20150958 with bla GES .
For the assessment of specificity and sensitivity, 310
Enterobacteriaceae isolates from the National Laboratory Surveillance for CRE from 2010 to 2017 were tested, which were previously characterized using conventional PCR and/ or sequencing analysis. Among them, 201 strains carried only 1 type of carbapenemase gene, and 24 strains carried several combinations of one or more carbapenemase genes.
The remaining 85 strains had none of the 6 carbapenemase genes. These strains included 26 Enterobacteriaceae species (Table 1) and variants of KPC (bla 3, 4, 6, 12, 19 ), NDM (bla NDM-1, 3, 4, 5, 6, 7 ), OXA-48 like (bla OXA-48, 181, 232 ), IMP (bla IMP-1, 4, 6 ), VIM (bla VIM-1, 2 ), and GES (bla ). All CPE isolates were confirmed by both the phenotypic method, and an in-house conventional PCR method, as previously described [14, 30] .
DNA preparation
All bacteria were grown on tryptic soy agar at 37°C overnight.
Genomic DNA from the reference strains used for triplex RT-PCR assay optimization was extracted using the Qiagen DNeasy 
Optimization of two triplex real-time PCR assays
The assays (Rx1 and Rx2) were performed on the ABI7500 
*Producing ≥ 2 carbapenemase genes. CPE = carbapenemase-producing Enterobacteriaceae; KPC = Klebsiella pneumoniae carbapenemase; NDM = New Delhi metallo-β-lactamase; OXA-48 like = oxacillinase; IMP = imipenem-hydrolyzing; VIM = Verona integron-encoded metallo-β-lactamase; GES = Guiana extended-spectrum β-lactamase. 
Results
Confirmation that the single primer pair, and designed probes produced the expected signal individually using monoplex real-time PCR for each target gene alongside positive-and negative-control DNA was performed. GES probe Dabcyl-GTGGCTGATCGG-ROX 10 KPC = Klebsiella pneumoniae carbapenemase; NDM = New Delhi metallo-β-lactamase; OXA-48 like = oxacillinase; IMP = imipenem-hydrolyzing; VIM = Verona integron-encoded metallo-β-lactamase; GES = Guiana extended-spectrum β-lactamase. showed 100% concordance between the previous conventional PCR, and newly developed triplex real-time PCR methods based on direct colony real-time PCR.
In all cases, the 6 target genes were detected with Ct values ranging from 10 to 35 (Supplementary Table S1 ). There was 
Discussion
Since the first report of non-metalloenzyme carbapenemase in 1993, CPE have been identified in many countries [31] .
However, until recently, CPE isolates were rarely detected in the Korean antimicrobial resistance surveillance system (Kor-GLASS), with a rate of less than 0.1% estimated in 2017 [30] .
However, increasing awareness of the sharp increase of CPE isolates reported from health settings prompted the need to intensify the strict preparedness of control strategies for the potential risks of the amplification and transmission of CPE within individual institutions in Korea.
Above all, early screening, and confirmation of carbapenemase producers cannot be overestimated for appropriate infection control, and treatment in acute hospital settings [32] . There is no perfect single laboratory diagnostic method available for rapidly detecting all known carbapenemases. The routine culture-based susceptibility tests to detect carbapenemase producers generally require additional confirmatory tests, and careful interpretation owing to varied levels of carbapenemase expression, and the poor specificity of some antibiotic combinations [33, 34] .
In addition, some exceptional cases cannot be detected with phenotypic testing methods, such as CPE with low-level carbapenem resistance or susceptibility to carbapenems (e.g., KPC, GES enzymes) [35, 36] . Moreover, the main drawback of the phenotypic testing method is the prolonged turnaround time of at least 24-72 hours. To overcome these limitations, various molecular-based diagnostic methods have been developed recently, as a first-line screening strategy of CPE infection, which are now being employed in hospital settings [37] .
In this study the applicability of a triplex real-time PCR A key drawback of any PCR-based method targeting limited types of carbapenemases is that other carbapenemase types cannot be detected, including novel types [38, 39] . Although the distribution of carbapenemase types differs widely among countries, even within regions, the representative 6 types of carbapenemases targeted in this study accounted for more than 97% of the total number of CPE strains collected by the national laboratory surveillance system of CNSE in Korea [14] .
Accordingly, these two assays are expected to cover a very high proportion of CPE in the country. Nevertheless, further research is needed to uncover novel carbapenemases or rare enzyme types that were not included in these assays.
In addition, we intend to examine whether these assays are applicable for the detection of carbapenemase genes in other gram-negative bacteria such as Acinetobacter spp. and Pseudomonas spp., and the feasibility of the assays in direct testing of clinical specimens or environmental swabs for screening of CPE carriage and/or patients in hospital settings.
Importantly, the entire assay flow, including DNA extraction, and real-time PCR, can be completed within only 2 hours. This fast turnaround time will markedly shorten the time to derive results, representing a significant advantage for initiating timely measures at a hospital and/or intensive care unit, and primary settings for outbreaks of CPE reported in Korea.
Moreover, our proposed broad triplex real-time PCR screening strategy would be suitable for epidemiologic surveys in an outbreak situation.
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